Objectives: Please note: This lecture aims to serve as an introduction to the session "BREAST SURGERY - Which implants and why" and is therefore NOT submitted with a classic structure.

Introduction: Breast augmentation remains one of the most commonly performed aesthetic procedures worldwide. Over the past few decades, significant advancements in breast implant technology have enabled surgeons to generate safer more aesthetically pleasing outcomes. Today, a large variety of silicone implants boasting different shapes, sizes, texture and shell compositions are available, each presenting its own unique set of challenges. From the evolution of various breast implants to the refinement of surgical techniques, each phase of evolution represents a fusion of scientific innovation, clinical

Materials / method: expertise and patient preference.
Interestingly, the ideal size and shape of the female breast are inherently subjective, often influenced by personal preference and cultural norms. Nevertheless, certain characteristics define an elegant and aeshtetically pleasing female breast, widely recognized among surgeons. For instance, the breast profile typically features a gently sloping or full upper pole, transitioning smoothly to the lower pole with a well-defined inframammary fold. Moreover, the nipple–areolar complex is ideally positioned at the point of maximal projection of the breast.

Results: Other crucial aspects include the breast’s position on the anterior chest wall, which determines the footprint upon which the breast parenchyma rests. Undoubtedly, the aesthetic outcome of breast augmentation is dependent on the dynamic interplay between the breast implant key native breast characteristics.

Conclusion: As an introduction to the session BREAST SURGERY – Which implants and why,' this talk discusses aesthetic characteristics of the breast and current insights into the various aspects and challenges of available implants. Understanding the advancements in late-generation implants empowers surgeons to criticalls evaluate results and promotes the provision of up-to-date scientific data on these devices, thereby enhancing the clinical outcome.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。